| IL320713A (en) | | Antibodies, uses and methods |
| IL283321A (en) | | Anti-muc16 antibodies and uses thereof |
| PT3347379T (en) | | Anti-tigit antibodies, anti-pvrig antibodies and combinations thereof |
| IL262497A (en) | | Anti-il-33 antibodies, compositions, methods and uses thereof |
| IL258284A (en) | | Anti-lag3 antibodies and uses thereof |
| ZA201704117B (en) | | Cd47 antibodies, methods, and uses |
| IL257263A (en) | | Anti-angptl8 antibodies and uses thereof |
| ZA201800536B (en) | | Il-8-binding antibodies and uses thereof |
| SG10202109691UA (en) | | Anti-pacap antibodies and uses thereof |
| IL254954B (en) | | Anti-pacap antibodies and uses thereof |
| ZA201901935B (en) | | Anti-il-33 antibodies and uses thereof |
| GB201512203D0 (en) | | Agents,uses and methods |
| IL252430A0 (en) | | Antibodies, uses and methods |
| ZA201806640B (en) | | Gitr antibodies, methods, and uses |
| PL3292154T3 (en) | | Anti-human-her3 antibodies and uses thereof |
| IL266082A (en) | | Anti-chikv antibodies and uses thereof |
| IL266049A (en) | | Anti-o1 antibodies and uses thereof |
| GB201503387D0 (en) | | Anti-carbapenem antibodies and uses thereof |
| IL264417A (en) | | Anti-o2 antibodies and uses thereof |
| IL257434A (en) | | Mrka polypeptides, antibodies, and uses thereof |
| GB201618515D0 (en) | | Combinations comprising antibodies, uses and methods |
| GB201713147D0 (en) | | Antibodies, combinations comprising antibodies, biomarkers, uses and methods |
| GB201512211D0 (en) | | Agents, uses and methods |